Medibank Private Ltd (ASX: MPL) shareholders might be feeling frustrated after the company’s share price tumbled 6% over the last week.
The private health insurer released its half-year results for the 2022 financial year, reporting single-digit increases across key metrics.
Nonetheless, the board opted to increase its upcoming interim dividend to eligible investors.
Let’s take a look below at what you need to know.
What’s the deal with Medibank interim dividend?
The Medibank share price backtracked late last week, which appears to have been caused by an underwhelming performance.
In total, the company will be paying out 6.1 cents per share for the 6 months ended 31 December 2021. That’s 5% higher than last year’s interim dividend for financial year 2021.
Furthermore, the payout ratio for the latest dividend is at 78.5% (in line with the target range of 75% – 85%).
Management noted that the full-year dividend for FY22 is expected to be towards the top end of the above target range.
The higher dividend came despite Medibank’s net profit after tax (NPAT) falling 2.7% to $220.2 million over the first half. It noted that a $40.9 million, or 57% decrease, in net investment income dragged down the company’s bottom line.
When can shareholders expect to be paid?
Medibank will pay the interim dividend to eligible shareholders next month on 24 March.
However, to be eligible you’ll need to own Medibank shares before the ex-dividend date on Friday 4 March. This means if you want to secure the dividend, you will need to purchase Medibank shares by Thursday 3 March at the latest.
It is worth noting that on the ex-dividend day, the share price traditionally falls in proportion to the dividend amount.
In addition, the dividend is fully-franked which means that investors will receive tax credits when tax time comes along.
Currently, Medibank has a dividend trailing yield of 4.16% and a market capitalisation of roughly $8.4 billion.
The post Own Medibank (ASX:MPL) shares? Here’s all you need to know about the latest dividend appeared first on The Motley Fool Australia.
Should you invest $1,000 in Medibank right now?
Before you consider Medibank, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- Medibank (ASX:MPL) share price backtracks as profit slips
- ASX 200 (ASX:XJO) midday update: Block rockets, Blackmores sinks
- 5 things to watch on the ASX 200 on Friday
- Medibank (ASX:MPL) share price lifts despite rumours of failed hospital bid
- Sweet dreams: ASX 200 shares that have provided big returns without the worry
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/TKGdM3E
Leave a Reply